🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
INDV.L
LSE
🇬🇧 UK ISA ✓
Indivior Pharmaceuticals Inc
Pharmaceuticals
23Score
DipBuster Score™
£0.000
+£0 (+0%)
Static data — add API keys for live prices
52-Week Position
£548.71
0% of range
£1,264.00
Beta
0.258
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.258
52W High£1,264.00
52W Low£548.71
🤖
Not a Dip — Score 23/100
Zone: Hold / Watch
🔒 Unlock Pro
Valuation
P/E Ratio—
Mkt CapN/A
52W Position0% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.258
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️
Insider Buys
Track director & CEO open-market purchases
📊
Valuation Analysis
P/E, EV/EBITDA, DCF & NCAV metrics
📈
Financial Charts
Revenue, EBITDA, FCF & balance sheet trends
🤖
AI Analysis
Plain-English explanation of every key metric
Sign up free — charts & fundamentals included
Get financial charts, valuation data, dividends & news for Indivior Pharmaceuticals Inc free. Upgrade to Pro for insider signals & AI analysis.
Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
10/25
Momentum & Volume
8/25
Quality & Size
5/10
Insider Activity
0/10
Quick Take
⚪
Not a Dip
DipBuster Score: 23/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
As a holding company, Indivior Pharmaceuticals Inc primarily focuses on the development, manufacturing, and distribution of buprenorphine-containing prescription drugs aimed at addressing opioid dependence. Key offerings…
Sector
Pharmaceuticals
Market
🇬🇧 LSE
CEO
Joseph J. Ciaffoni
Staff
1,030 employees
Website